Dashboard
Weak Long Term Fundamental Strength with a -28.26% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.72
- The company has been able to generate a Return on Equity (avg) of 3.22% signifying low profitability per unit of shareholders funds
Risky - Negative Operating Profits
Stock DNA
Specialty Chemicals
INR 87 Cr (Micro Cap)
184.00
32
0.21%
0.42
2.53%
4.70
Total Returns (Price + Dividend) 
Latest dividend: 0.3 per share ex-dividend date: Sep-23-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Kemistar Corporation Faces Intense Selling Pressure Amid Consecutive Losses
Kemistar Corporation, a key player in the Specialty Chemicals sector, is currently experiencing severe selling pressure with no buyers visible in the market. The stock’s performance over recent months and years reveals a pattern of sustained declines against broader market gains, signalling distress selling and heightened investor caution.
Read More
Kemistar Corporation Faces Intense Selling Pressure Amid Consecutive Losses
Kemistar Corporation is experiencing severe selling pressure with no buyers present, resulting in a sharp decline in its share price. The stock has recorded consecutive losses across multiple time frames, significantly underperforming the broader market and its sector peers.
Read More
Kemistar Corporation Evaluation Sees Shift Amid Mixed Financial and Technical Signals
Kemistar Corporation, a player in the Specialty Chemicals sector, has experienced a notable shift in its market evaluation, reflecting a complex interplay of financial performance, valuation metrics, and technical indicators. This article analyses the recent changes in the company’s assessment across four key parameters: quality, valuation, financial trend, and technicals.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Press Release / Media Release
27-Nov-2025 | Source : BSEQ2 FY 2025-26 Results Review
Announcement under Regulation 30 (LODR)-Newspaper Publication
13-Nov-2025 | Source : BSENewspaper Publication of the Unaudited Financial Results for the quarter and half year ended September 30 2025.
Board Meeting Outcome for Approval Of Unaudited Financial Results For The Quarter Ended September 30 2025
11-Nov-2025 | Source : BSEApproval of Unaudited Financial Results For The Quarter Ended September 30 2025
Corporate Actions 
No Upcoming Board Meetings
Kemistar Corporation Ltd has declared 3% dividend, ex-date: 23 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Ketankumar Parashottamdas Patel (27.39%)
Kirit Jivrajbhai Patel (1.4%)
22.49%
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
YoY Growth in quarter ended Sep 2025 is 127.59% vs 22.80% in Sep 2024
YoY Growth in quarter ended Sep 2025 is -92.31% vs 0.00% in Sep 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 54.67% vs 43.22% in Sep 2024
Growth in half year ended Sep 2025 is -53.85% vs 18.18% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 61.63% vs -53.98% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -11.11% vs -53.25% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 63.87% vs -39.08% in Mar 2024
YoY Growth in year ended Mar 2025 is 13.21% vs -36.90% in Mar 2024






